Trial site
California Neuroscience Research Medical Group, Inc.
- 4running trials
- 6closed trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease3 trials
- Migraine2 trials
- Depression1 trial
- Phase
- Phase 37 trials
- Phase 21 trial
- Phase 2/31 trial
- Phase 41 trial
- Status
- Completed3 trials
- Terminated3 trials
- Active, not recruiting2 trials
- Not yet recruiting1 trial
- Recruiting1 trial
- Lead sponsor
- Biohaven Pharmaceuticals, Inc.3 trials
- Eli Lilly and Company3 trials
- Pfizer2 trials
- Biogen1 trial
- Otsuka Pharmaceutical Development & Commercialization, Inc.1 trial
Running trials
Not yet recruiting
A Study of Brenipatide in Participants With Major Depressive Disorder
Recruiting
Active, not recruiting
Active, not recruiting
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Depression1 recruiting
Closed trials
Completed
Terminated
Long-term Safety Study of Adjunctive Troriluzole in Subjects With Obsessive Compulsive Disorder
Terminated
A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention
Completed
Completed
Efficacy and Safety Study of Adjunctive Troriluzole in Obsessive Compulsive Disorder
Terminated
Site data: ClinicalTrials.govUpdated 18 Nov 2026